UnknownNot Applicable

Fractional co2 Laser Followed by Either Vitamin c or Tranexamic Acid in Treatment of Melasma.

25 participantsStarted 2023-10-28

Plain-language summary

The aim of the study: 1.To compare the efficacy and safety of fractional CO2 laser in combination with vitamin c and tranexamic acid in the treatment of melasma. 2 .To assess the value of dermoscope in measuring of the response to treatment in melasma patients compared to clinical scoring.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. All types of melasma (epidermal, dermal, and mixed) will be included .
✓. Patients older than 19 years of age.

Exclusion criteria

✕. Pregnancy, breastfeeding.
✕. Patients taking drugs that induce facial pigmentation e.g, oral contraceptive pills, or hormonal replacement therapy at the time of the study or during the past 12 months.
✕. Patients using of any topical bleaching within 1 month before recruitment.
✕. Employment of chemical peels or laser therapy during the past 6 months.
✕. Concomitant use of anticoagulants, bleeding disorders.

What they're measuring

Efficacy and safety of fractional CO2 laser in treatment of melasma.

Timeframe: 1year

Trial details

NCT IDNCT05911698

SponsorKhadija Qenawi

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03

Contact for this trial

Khadija Qenawi, Doctor

+201140109931 diganova796@gmail.com

View on ClinicalTrials.gov More Melasma trials